Core Viewpoint - Decon Agriculture (02419) reported its sales performance for July 2025, indicating a decline in average selling prices for both pork and chicken products compared to the previous month [1] Sales Performance - In July 2025, the company sold 780,200 pigs, including 741,900 commercial pigs, generating sales revenue of RMB 1.427 billion [1] - The average selling price for commercial pigs in July 2025 was RMB 14.21 per kilogram, a decrease of 0.70% from June 2025 [1] - For the seven months ending July 31, 2025, the company sold a total of 5.8975 million pigs, with 5.5862 million being commercial pigs, resulting in total sales revenue of RMB 11.449 billion [1] Poultry Sales - In July 2025, the company sold 7.3826 million yellow-feathered broilers, achieving sales revenue of RMB 204 million [1] - The average selling price for yellow-feathered broilers in July 2025 was RMB 12.04 per kilogram, down 6.52% from June 2025 [1] - For the seven months ending July 31, 2025, the company sold a total of 50.0859 million yellow-feathered broilers, generating sales revenue of RMB 1.506 billion [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部 分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 DEKON FOOD AND AGRICULTURE GROUP 四川德康農牧食品集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代碼：2419） 自願公告 2025年7月運營快報 本公告乃四川德康農牧食品集團股份有限公司（「本公司」，連同其附屬公司，「本集 團」）作出的自願公告。 本公司董事會（「董事會」）謹此宣佈，本集團2025年7月的主要運營數據（未經審核） 如下： 生豬板塊 | | | | | | 商品肉豬 | | --- | --- | --- | --- | --- | --- | | | 生豬銷量 | | 銷售收入 | | 平均售價 | | | | | | | （人民幣 | | | （千頭） 本期間數量 | 本年累計數量 | （人民幣百萬元） 本期間金額 | 本年累計金額 | 元╱公斤） | | 2024年6月 | 698.35 | 4,026.14 | 1,611.37 ...

Investment Rating - The report maintains a "Strong Buy" investment rating for the company [3][6]. Core Views - The company has shown impressive performance in its pig farming business, with per-head profitability leading the industry. The poultry and meat business performance met expectations. The company is actively responding to national policies promoting high-quality development in the farming industry, sharing the benefits of industrial growth with partner farmers, and demonstrating its responsibility as a leading player in the sector [1][6]. - The company is expected to achieve a significant increase in net profit for the first half of 2025, estimated between 1.1 billion to 1.4 billion yuan, representing a year-on-year growth of 202% to 285%. This growth is attributed to improved management efficiency, enhanced economies of scale, and a continuous decline in pig farming costs [6][12]. - The company is positioned to gain excess profits due to its cost advantages in pig farming, with expectations for a recovery in the poultry market in the second half of the year. The report highlights the potential for the company to leverage its breeding advantages to maintain a leading position in the industry [6][12]. Financial Data and Valuation - The company’s total revenue is projected to grow from 16.155 billion yuan in 2023 to 42.802 billion yuan in 2027, with a compound annual growth rate (CAGR) of approximately 29% [2][13]. - The operating profit is expected to recover from a loss of 1.297 billion yuan in 2023 to a profit of 6.995 billion yuan by 2027, indicating a significant turnaround [2][13]. - The net profit attributable to shareholders is forecasted to increase from a loss of 1.775 billion yuan in 2023 to 8.332 billion yuan in 2027, reflecting a strong recovery trajectory [2][15]. - The report provides earnings per share (EPS) estimates of 10.02 yuan for 2025, 14.64 yuan for 2026, and 21.43 yuan for 2027, indicating a positive outlook for profitability [2][15]. Business Segments - In the pig farming segment, the company is expected to sell approximately 5.117 million pigs in the first half of 2025, with an average selling price of about 15 yuan per kilogram, leading to a per-head profit of approximately 300 to 320 yuan, which is among the highest in the industry [6][12]. - The poultry segment, specifically the yellow feathered chicken business, is projected to see a slight increase in output, with the company focusing on enhancing the quality and market share of its products [6][12].

Major Events - Silver诺医药-B (02591) is set to conduct an IPO from August 7 to August 12, with an expected listing date of August 15 [1] - Boan Biotech (06955) plans to place 48 million shares at a discount of approximately 8.78%, aiming to raise about HKD 780 million [1] - Derin Holdings (01709) intends to raise HKD 653.3 million, focusing on the development of blockchain, RWA, and virtual asset businesses [1] - Fuhong Hanlin (02696) received FDA approval to initiate a Phase 1 clinical trial for HLX43, a PD-L1 targeted antibody-drug conjugate for thymic cancer treatment [1] - China Biopharmaceutical (01177) obtained NMPA approval for the Phase II clinical trial application of LM-24C5, a dual antibody targeting CEACAM5/4-1BB [1] Financial Reports - China Mobile (00941) reported a shareholder profit of HKD 84.235 billion, a year-on-year increase of 5.03% [1] - Manulife Financial-S (00945) announced a core profit of CAD 1.7 billion for the second quarter [1] - Swire Properties (01972) reported a basic profit attributable to shareholders of HKD 4.42 billion, a year-on-year growth of 15% [1] - Hutchison Whampoa (00013) posted a net profit of USD 455 million, a significant year-on-year increase of 1663.32% [1] - MGM China (02282) disclosed a net profit of HKD 2.383 billion, a year-on-year decrease of 11.25% [1] - SMIC (00981) reported a shareholder profit of USD 132 million for the second quarter, with a revenue guidance for the third quarter indicating a sequential growth of 5% to 7% [1] - Zai Lab (09688) achieved a total revenue of approximately USD 216 million for the first half of the year, reflecting a year-on-year growth of 15.35% [1] - Innovent Biologics (01801) reported total product revenue exceeding RMB 5.2 billion for the first half of the year, maintaining a strong growth rate of over 35% [1] - Pacific Basin Shipping (02343) announced a profit attributable to shareholders of USD 25.6 million, a year-on-year decrease of 56% [1] - Lee & Man Paper Manufacturing (02314) reported a net profit of HKD 811 million, a year-on-year increase of 0.7%, with an interim dividend of HKD 0.066 per share [1] - Swire Group reported a profit attributable to shareholders of HKD 815 million for the first half of the year, a year-on-year decrease of 79% [1] - Lee & Man Chemical Company (00746) reported a profit increase of 36.0% to HKD 327 million, with an interim dividend of HKD 0.195 per share [1] - Hua Hong Semiconductor (01347) reported a profit attributable to parent company owners of USD 7.952 million for the second quarter, a year-on-year increase of 19.2% [1] - Wharf Real Estate Investment (01997) reported a loss attributable to shareholders of HKD 2.406 billion, a year-on-year increase of 128.71%, with the first interim dividend of HKD 0.066 per share [1] - Dekang Agriculture (02419) issued a profit warning, expecting a year-on-year increase in fair value adjustments of biological assets to approximately RMB 1.1 billion to 1.4 billion [1] - Mongol Mining (00975) issued a profit warning, anticipating a net loss of approximately USD 15 million to 25 million for the first half of the year, marking a shift from profit to loss [1] - Dongfeng Motor Group (00489) issued a profit warning, expecting a decline in net profit attributable to the parent company of 90% to 95% for the first half of the year [1]

Core Viewpoint - Dekang Agriculture (02419.HK) expects a significant increase in profit for the six months ending June 30, 2025, with projected earnings before fair value adjustments of biological assets between RMB 1,100 million and RMB 1,400 million, compared to RMB 363 million for the same period in 2024, driven by improved management efficiency and reduced costs of pig production [1]. Financial Performance - The projected profit for the upcoming period represents a substantial increase from the previous year's earnings, indicating a growth of approximately 203% to 286% [1]. - The increase in profitability is attributed to enhanced management effectiveness and economies of scale, alongside a continuous decline in pig production costs [1].

Core Viewpoint - Dekang Agriculture (02419) expects to achieve a profit before fair value adjustment of biological assets of approximately RMB 1.1 billion to RMB 1.4 billion for the six months ending June 30, 2025, compared to a profit of approximately RMB 363 million for the same period in 2024 [1] Group 1 - The expected increase in profit is primarily attributed to improved management efficiency and enhanced economies of scale [1] - The continuous decline in pig costs is also a significant factor contributing to the anticipated profit growth [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部 分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （股份代碼：2419） 內幕消息 盈利預喜 本公告乃四川德康農牧食品集團股份有限公司（「本公司」，連同其附屬公司，「本集 團」）根據香港法例第571章《證券及期貨條例》第XIVA部內幕消息條文及香港聯合 交易所有限公司證券上市規則（「《上市規則》」）第13.09條而作出。 本公司董事（「董事」）會（「董事會」）謹此通知本公司股東及潛在投資者，根據對本集 團截至2025年6月30日止六個月的未經審核綜合管理賬目及董事會現時所獲資料的 初步評估，本集團預期截至2025年6月30日止六個月將錄得生物資產公允價值調整 前利潤約人民幣1,100百萬元至人民幣1,400百萬元，而2024年同期錄得生物資產公 允價值調整前盈利約人民幣363百萬元。預期盈利上升主要歸因於公司管理效能、 規模化效應進一步提升，生豬成本持續下降。 本公司現正落實本集團截至2025年6月30日止六個月之中期業績公告。本公告所載 資料僅為董事會 ...

Core Viewpoint - The company, Dekang Agriculture (02419.HK), announced that it will hold a board meeting on August 15, 2025, to consider and approve its interim results for the six months ending June 30, 2025, and to discuss the potential declaration of an interim dividend, if applicable [1] Summary by Categories - **Company Announcement** - The board meeting is scheduled for August 15, 2025 [1] - The meeting will focus on the approval of interim results for the period ending June 30, 2025 [1] - The company will also consider the recommendation for an interim dividend [1]

四川德康農牧食品集團股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公 司將於二零二五年八月十五日（星期五）舉行董事會會議，藉以（其中包括）考慮及批 准本公司及其附屬公司截至二零二五年六月三十日止六個月的中期業績及其刊發， 並考慮建議派發中期股息（如有）。 承董事會命 四川德康農牧食品集團股份有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 DEKON FOOD AND AGRICULTURE GROUP 四川德康農牧食品集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代碼：2419） 董事會會議召開日期 董事長兼執行董事 王德根 香港，二零二五年八月五日 於本公告日期，本公司執行董事為王德根先生、王德輝先生、姚海龍先生、胡偉先 生及曾民先生；本公司非執行董事為劉珊女士；及本公司獨立非執行董事為潘鷹先 生、朱慶先生及馮志偉先生。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 四川德康農牧食品集團股份有限公司 (於中華人民共和國註冊成立的股份有限公司) 呈交日期: 2025年8月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02419 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 157,588,454 | RMB | | 1 | RMB | | 157,588,454 | | 增加 / 減少 (-) | | | | | | | RMB | | | | 本月底結存 | | | 157,588,454 | RMB | | 1 | RMB | | 157,58 ...